Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Friday, May 22, 2009
J&J buy Cougar for abiraterone
Johnson & Johnson has signed an agreement to acquire Cougar Biotechnology for just under $1 billion, a deal which will give it access to the much-touted investigational prostate cancer drug abiraterone.
No comments:
Post a Comment